We’re thrilled to be featured in the latest OSIC Partner Spotlight, where Chuck Hatt, our Vice President of Medical & Clinical Affairs, discusses 4DMedical’s leadership in transforming pulmonary diagnostics. The blog highlights our commitment to advancing lung health through innovative, non-invasive imaging solutions powered by AI, including the FDA-cleared IQ-UIP™ software developed to improve early detection of idiopathic pulmonary fibrosis (IPF).
Chuck details how OSIC’s world-class imaging data repository and collaborative network have been instrumental in accelerating the development and regulatory approval of 4DMedical technologies. The partnership has not only enabled faster innovation but also fostered valuable connections across the medical, scientific, and patient advocacy communities.
The article also offers a look ahead at 4DMedical’s upcoming advancements, such as our Lung Texture Analysis and CT:VQ™ solutions, underscoring our ongoing dedication to improving patient outcomes in respiratory care.
We invite you to read the full OSIC Q&A for more insight into how 4DMedical and OSIC are working together to shape the future of pulmonary medicine.